Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ontak in Low or Intermediate Grade B-Cell Non-Hodgkin's Lymphoma
NCT00026429Phase 2Unknown
- Sponsor
- Pharmatech Oncology
- Start
- Jan 2001
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 2 trial of denileukin diftitox in B-cell non-Hodgkin lymphoma, sponsored by Pharmatech Oncology. Status: unknown.
02
Drugs
denileukin diftitox
03
Conditions
B-cell non-Hodgkin lymphoma
Beyond the preview
Go deeper on NCT00026429.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00026429.